Rafarma Pharmaceuticals Inc (RAFA)
0.085
0.00 (0.00%)
USD |
OTCM |
May 24, 12:53
Rafarma Pharmaceuticals Max Drawdown (5Y): 96.71% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 96.71% |
March 31, 2024 | 95.77% |
February 29, 2024 | 95.77% |
January 31, 2024 | 95.77% |
December 31, 2023 | 96.55% |
November 30, 2023 | 98.00% |
October 31, 2023 | 98.24% |
September 30, 2023 | 99.29% |
August 31, 2023 | 99.37% |
July 31, 2023 | 99.37% |
June 30, 2023 | 99.37% |
May 31, 2023 | 99.37% |
April 30, 2023 | 99.37% |
March 31, 2023 | 99.37% |
February 28, 2023 | 99.37% |
January 31, 2023 | 99.37% |
December 31, 2022 | 99.37% |
November 30, 2022 | 99.37% |
October 31, 2022 | 99.37% |
September 30, 2022 | 99.37% |
August 31, 2022 | 99.37% |
July 31, 2022 | 99.37% |
June 30, 2022 | 99.37% |
May 31, 2022 | 99.37% |
April 30, 2022 | 99.78% |
Date | Value |
---|---|
March 31, 2022 | 99.78% |
February 28, 2022 | 99.78% |
January 31, 2022 | 99.86% |
December 31, 2021 | 99.86% |
November 30, 2021 | 99.86% |
October 31, 2021 | 99.86% |
September 30, 2021 | 99.86% |
August 31, 2021 | 99.86% |
July 31, 2021 | 99.86% |
June 30, 2021 | 99.86% |
May 31, 2021 | 99.86% |
April 30, 2021 | 99.86% |
March 31, 2021 | 99.86% |
February 28, 2021 | 99.86% |
January 31, 2021 | 99.86% |
December 31, 2020 | 99.86% |
November 30, 2020 | 99.86% |
October 31, 2020 | 99.86% |
September 30, 2020 | 99.86% |
August 31, 2020 | 99.86% |
July 31, 2020 | 99.86% |
June 30, 2020 | 99.86% |
May 31, 2020 | 99.86% |
April 30, 2020 | 99.86% |
March 31, 2020 | 99.86% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
95.77%
Minimum
Jan 2024
99.86%
Maximum
May 2019
99.34%
Average
99.86%
Median
Feb 2021
Max Drawdown (5Y) Benchmarks
NovaBay Pharmaceuticals Inc | 99.91% |
Palatin Technologies Inc | 96.46% |
iBio Inc | 99.97% |
Theriva Biologics Inc | 99.81% |
Oragenics Inc | 98.92% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | 24.34 |
Beta (5Y) | -0.1119 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 155.7% |
Historical Sharpe Ratio (5Y) | 0.1483 |
Historical Sortino (5Y) | 0.5837 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 35.02% |